| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ion Channels | 83 | 2022 | 234 | 16.560 |
Why?
|
| Protons | 54 | 2022 | 104 | 11.880 |
Why?
|
| Ion Channel Gating | 53 | 2022 | 196 | 10.700 |
Why?
|
| NADPH Oxidases | 25 | 2020 | 55 | 4.420 |
Why?
|
| Respiratory Burst | 17 | 2016 | 34 | 3.160 |
Why?
|
| Neutrophils | 12 | 2016 | 110 | 2.650 |
Why?
|
| Phagocytes | 12 | 2016 | 24 | 2.580 |
Why?
|
| Membrane Potentials | 36 | 2019 | 185 | 2.290 |
Why?
|
| Animals | 75 | 2022 | 3780 | 2.210 |
Why?
|
| Hydrogen-Ion Concentration | 36 | 2022 | 149 | 2.200 |
Why?
|
| Zinc | 15 | 2020 | 47 | 2.170 |
Why?
|
| Eosinophils | 8 | 2006 | 47 | 1.590 |
Why?
|
| Models, Molecular | 9 | 2018 | 84 | 1.580 |
Why?
|
| Pulmonary Alveoli | 14 | 2004 | 29 | 1.570 |
Why?
|
| Patch-Clamp Techniques | 25 | 2019 | 114 | 1.460 |
Why?
|
| Potassium Channels | 14 | 2004 | 39 | 1.280 |
Why?
|
| Mutation | 11 | 2019 | 353 | 1.220 |
Why?
|
| Humans | 81 | 2020 | 28408 | 1.180 |
Why?
|
| Aspartic Acid | 4 | 2017 | 14 | 1.140 |
Why?
|
| Electrophysiology | 22 | 2010 | 103 | 1.130 |
Why?
|
| Scientific Misconduct | 2 | 2022 | 3 | 1.080 |
Why?
|
| Proton Pumps | 6 | 2008 | 16 | 1.060 |
Why?
|
| Budgets | 2 | 2019 | 2 | 1.020 |
Why?
|
| Biomedical Research | 2 | 2019 | 66 | 0.900 |
Why?
|
| Kinetics | 27 | 2010 | 194 | 0.880 |
Why?
|
| Retraction of Publication as Topic | 1 | 2022 | 1 | 0.820 |
Why?
|
| Cell Membrane | 5 | 2019 | 90 | 0.800 |
Why?
|
| Potassium | 21 | 2004 | 66 | 0.770 |
Why?
|
| Monocytes | 4 | 2011 | 64 | 0.760 |
Why?
|
| Peer Review, Research | 2 | 2015 | 8 | 0.750 |
Why?
|
| Research Support as Topic | 2 | 2013 | 14 | 0.740 |
Why?
|
| HEK293 Cells | 6 | 2019 | 67 | 0.720 |
Why?
|
| Signal Transduction | 7 | 2018 | 447 | 0.700 |
Why?
|
| Protein Conformation | 7 | 2019 | 74 | 0.700 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2011 | 25 | 0.680 |
Why?
|
| Oocytes | 1 | 2019 | 7 | 0.670 |
Why?
|
| Tetradecanoylphorbol Acetate | 11 | 2009 | 40 | 0.660 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2019 | 3 | 0.650 |
Why?
|
| Emigration and Immigration | 1 | 2019 | 15 | 0.640 |
Why?
|
| Politics | 1 | 2019 | 11 | 0.640 |
Why?
|
| Molecular Dynamics Simulation | 3 | 2019 | 9 | 0.630 |
Why?
|
| Mice | 19 | 2020 | 1461 | 0.630 |
Why?
|
| Reactive Oxygen Species | 8 | 2016 | 119 | 0.620 |
Why?
|
| Potassium Channels, Voltage-Gated | 5 | 2000 | 12 | 0.610 |
Why?
|
| Water | 2 | 2017 | 32 | 0.610 |
Why?
|
| Point Mutation | 1 | 2018 | 27 | 0.600 |
Why?
|
| Protein Multimerization | 3 | 2013 | 18 | 0.590 |
Why?
|
| Electrons | 5 | 2011 | 21 | 0.590 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 3 | 2007 | 4 | 0.580 |
Why?
|
| Rats | 18 | 2018 | 678 | 0.580 |
Why?
|
| Hydrogen | 4 | 2004 | 12 | 0.580 |
Why?
|
| Membrane Glycoproteins | 3 | 2002 | 72 | 0.570 |
Why?
|
| Phylogeny | 3 | 2013 | 48 | 0.570 |
Why?
|
| Dinoflagellida | 2 | 2017 | 4 | 0.520 |
Why?
|
| Microglia | 5 | 2001 | 145 | 0.520 |
Why?
|
| Neoplasms | 1 | 2019 | 239 | 0.520 |
Why?
|
| Molecular Sequence Data | 7 | 2015 | 199 | 0.510 |
Why?
|
| T-Lymphocytes | 12 | 2002 | 97 | 0.510 |
Why?
|
| Epithelial Cells | 7 | 2004 | 84 | 0.500 |
Why?
|
| Lipid Bilayers | 1 | 2015 | 57 | 0.500 |
Why?
|
| Amino Acid Sequence | 6 | 2015 | 160 | 0.480 |
Why?
|
| Models, Biological | 9 | 2021 | 326 | 0.470 |
Why?
|
| Phagocytosis | 4 | 2010 | 44 | 0.460 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 43 | 0.460 |
Why?
|
| In Vitro Techniques | 13 | 2009 | 176 | 0.460 |
Why?
|
| Electric Conductivity | 12 | 2013 | 71 | 0.460 |
Why?
|
| Viral Matrix Proteins | 1 | 2013 | 3 | 0.450 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 11 | 0.450 |
Why?
|
| Aquaporins | 1 | 2013 | 7 | 0.450 |
Why?
|
| COS Cells | 6 | 2015 | 43 | 0.430 |
Why?
|
| Superoxides | 7 | 2012 | 25 | 0.430 |
Why?
|
| Economic Development | 1 | 2013 | 3 | 0.430 |
Why?
|
| Policy Making | 1 | 2013 | 14 | 0.430 |
Why?
|
| Administrative Personnel | 1 | 2013 | 9 | 0.430 |
Why?
|
| Basophils | 3 | 2010 | 9 | 0.420 |
Why?
|
| Research | 1 | 2013 | 43 | 0.420 |
Why?
|
| Propaganda | 1 | 2012 | 1 | 0.410 |
Why?
|
| Public Opinion | 1 | 2012 | 5 | 0.410 |
Why?
|
| Climate Change | 1 | 2012 | 15 | 0.410 |
Why?
|
| Proton-Motive Force | 4 | 2021 | 7 | 0.400 |
Why?
|
| Neoplasm Proteins | 3 | 1996 | 54 | 0.390 |
Why?
|
| Research Personnel | 2 | 2009 | 20 | 0.380 |
Why?
|
| Glucose | 1 | 2011 | 55 | 0.370 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2021 | 11 | 0.360 |
Why?
|
| Rubidium | 4 | 1994 | 5 | 0.350 |
Why?
|
| Membrane Proteins | 3 | 2020 | 171 | 0.340 |
Why?
|
| Threonine | 1 | 2009 | 10 | 0.340 |
Why?
|
| Snails | 3 | 2018 | 6 | 0.340 |
Why?
|
| Blood Bactericidal Activity | 2 | 2007 | 5 | 0.340 |
Why?
|
| Leukocytes | 1 | 2009 | 38 | 0.330 |
Why?
|
| Histidine | 3 | 2018 | 8 | 0.330 |
Why?
|
| Enzyme Activation | 6 | 2010 | 120 | 0.330 |
Why?
|
| Cells, Cultured | 10 | 2011 | 539 | 0.330 |
Why?
|
| Delivery of Health Care | 1 | 2011 | 155 | 0.330 |
Why?
|
| Endothelium, Vascular | 4 | 1994 | 49 | 0.330 |
Why?
|
| Cell Line | 8 | 2012 | 280 | 0.320 |
Why?
|
| B-Lymphocytes | 5 | 2014 | 56 | 0.310 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 11 | 0.310 |
Why?
|
| Cation Transport Proteins | 2 | 1998 | 4 | 0.310 |
Why?
|
| Trans-Activators | 2 | 1998 | 25 | 0.300 |
Why?
|
| Cadmium | 4 | 2018 | 13 | 0.300 |
Why?
|
| Protein Domains | 2 | 2018 | 7 | 0.300 |
Why?
|
| Protein Kinase C | 2 | 2014 | 52 | 0.300 |
Why?
|
| Hypersensitivity | 1 | 2008 | 48 | 0.290 |
Why?
|
| Membrane Transport Modulators | 1 | 2007 | 2 | 0.280 |
Why?
|
| Phospholipases A | 1 | 2006 | 7 | 0.280 |
Why?
|
| Granulocytes | 1 | 2006 | 16 | 0.270 |
Why?
|
| Bacterial Infections | 1 | 2007 | 52 | 0.270 |
Why?
|
| Immunity, Innate | 1 | 2007 | 58 | 0.270 |
Why?
|
| Leukemia, Monocytic, Acute | 2 | 1996 | 4 | 0.270 |
Why?
|
| DNA-Binding Proteins | 2 | 1998 | 274 | 0.260 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 281 | 0.260 |
Why?
|
| Binding Sites | 2 | 2020 | 75 | 0.250 |
Why?
|
| Publishing | 1 | 2006 | 39 | 0.250 |
Why?
|
| Sodium-Hydrogen Exchangers | 3 | 2022 | 8 | 0.250 |
Why?
|
| Models, Theoretical | 2 | 2003 | 84 | 0.250 |
Why?
|
| Energy Metabolism | 2 | 2000 | 55 | 0.240 |
Why?
|
| Intracellular Membranes | 1 | 2004 | 22 | 0.240 |
Why?
|
| Cations, Divalent | 3 | 1999 | 11 | 0.240 |
Why?
|
| Chlorides | 5 | 2006 | 26 | 0.230 |
Why?
|
| Epithelium | 9 | 1995 | 29 | 0.230 |
Why?
|
| Arachidonic Acid | 2 | 2001 | 17 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2004 | 341 | 0.220 |
Why?
|
| Carbon Dioxide | 2 | 2022 | 20 | 0.220 |
Why?
|
| Species Specificity | 4 | 2013 | 42 | 0.220 |
Why?
|
| Static Electricity | 2 | 2021 | 43 | 0.210 |
Why?
|
| United States | 3 | 2019 | 2197 | 0.210 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2012 | 5 | 0.210 |
Why?
|
| Carcinogens | 3 | 2009 | 11 | 0.200 |
Why?
|
| Dimerization | 2 | 2013 | 21 | 0.200 |
Why?
|
| Electromagnetic Fields | 1 | 2021 | 8 | 0.190 |
Why?
|
| Phosphorylation | 3 | 2014 | 149 | 0.190 |
Why?
|
| Cricetinae | 2 | 2018 | 37 | 0.190 |
Why?
|
| Protein Binding | 3 | 2015 | 132 | 0.180 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 92 | 0.180 |
Why?
|
| Lymphocyte Activation | 8 | 1987 | 86 | 0.180 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2000 | 7 | 0.180 |
Why?
|
| Microscopy, Confocal | 3 | 2010 | 93 | 0.180 |
Why?
|
| Temperature | 3 | 2010 | 66 | 0.180 |
Why?
|
| Muscles | 4 | 1984 | 57 | 0.170 |
Why?
|
| Chloride Channels | 2 | 1997 | 8 | 0.170 |
Why?
|
| Macrophages | 3 | 1996 | 108 | 0.170 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2000 | 7 | 0.170 |
Why?
|
| Proton-Translocating ATPases | 1 | 2000 | 4 | 0.170 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2020 | 17 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2010 | 316 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 112 | 0.170 |
Why?
|
| Amino Acids | 1 | 2019 | 17 | 0.170 |
Why?
|
| Verapamil | 4 | 1995 | 26 | 0.170 |
Why?
|
| Cryopreservation | 1 | 2019 | 17 | 0.170 |
Why?
|
| Cell Proliferation | 1 | 2020 | 178 | 0.160 |
Why?
|
| Mexico | 1 | 2019 | 18 | 0.160 |
Why?
|
| Benzopyrans | 2 | 2009 | 9 | 0.160 |
Why?
|
| Substrate Specificity | 2 | 2011 | 23 | 0.160 |
Why?
|
| HL-60 Cells | 1 | 1998 | 14 | 0.160 |
Why?
|
| Isotonic Solutions | 2 | 2011 | 11 | 0.160 |
Why?
|
| Maleimides | 2 | 2009 | 8 | 0.150 |
Why?
|
| Sequence Homology | 1 | 2018 | 3 | 0.150 |
Why?
|
| Indoles | 2 | 2009 | 38 | 0.150 |
Why?
|
| NADPH Oxidase 2 | 3 | 2002 | 6 | 0.150 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 120 | 0.150 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2008 | 14 | 0.150 |
Why?
|
| Conserved Sequence | 1 | 2017 | 8 | 0.150 |
Why?
|
| Amino Acid Motifs | 1 | 2017 | 18 | 0.150 |
Why?
|
| Fluorescent Dyes | 2 | 2009 | 38 | 0.140 |
Why?
|
| Deuterium Oxide | 1 | 1997 | 2 | 0.140 |
Why?
|
| Tetraethylammonium Compounds | 6 | 1996 | 6 | 0.140 |
Why?
|
| Vacuoles | 1 | 2017 | 6 | 0.140 |
Why?
|
| CHO Cells | 1 | 1997 | 12 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 60 | 0.140 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 1996 | 1 | 0.130 |
Why?
|
| Permeability | 3 | 2011 | 120 | 0.130 |
Why?
|
| Sodium | 5 | 2022 | 64 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2006 | 351 | 0.130 |
Why?
|
| Potassium Channel Blockers | 1 | 1995 | 5 | 0.130 |
Why?
|
| Tryptophan | 1 | 2015 | 9 | 0.130 |
Why?
|
| Zinc Compounds | 2 | 2006 | 5 | 0.130 |
Why?
|
| Calcium Channel Blockers | 1 | 1995 | 33 | 0.120 |
Why?
|
| Mammals | 3 | 2022 | 26 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2015 | 15 | 0.120 |
Why?
|
| Spermatozoa | 2 | 2012 | 9 | 0.120 |
Why?
|
| Electric Stimulation | 4 | 2000 | 53 | 0.120 |
Why?
|
| Adult | 5 | 2009 | 8097 | 0.120 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2014 | 15 | 0.120 |
Why?
|
| Ammonia | 2 | 1991 | 3 | 0.120 |
Why?
|
| Hematologic Neoplasms | 1 | 2014 | 17 | 0.120 |
Why?
|
| Cesium | 2 | 1991 | 14 | 0.120 |
Why?
|
| Ion Pumps | 1 | 1994 | 2 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 735 | 0.110 |
Why?
|
| Binding, Competitive | 2 | 2007 | 24 | 0.110 |
Why?
|
| Mutation, Missense | 2 | 2013 | 26 | 0.110 |
Why?
|
| Granulomatous Disease, Chronic | 2 | 2005 | 8 | 0.110 |
Why?
|
| Algorithms | 3 | 2003 | 377 | 0.110 |
Why?
|
| Acids | 2 | 2022 | 4 | 0.110 |
Why?
|
| Structural Homology, Protein | 1 | 2013 | 5 | 0.110 |
Why?
|
| Homeostasis | 1 | 2013 | 67 | 0.100 |
Why?
|
| Calcium | 8 | 2002 | 381 | 0.100 |
Why?
|
| Oxygen Consumption | 2 | 2003 | 51 | 0.100 |
Why?
|
| Plankton | 1 | 2012 | 1 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 34 | 0.100 |
Why?
|
| Open Reading Frames | 1 | 2011 | 10 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2011 | 7 | 0.100 |
Why?
|
| Sucrose | 1 | 2011 | 18 | 0.100 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 20 | 0.100 |
Why?
|
| Lysine | 1 | 2011 | 15 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2011 | 56 | 0.090 |
Why?
|
| Cell Membrane Permeability | 2 | 2010 | 58 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 249 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 6 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2010 | 19 | 0.090 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 40 | 0.090 |
Why?
|
| Magnesium | 1 | 1990 | 36 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 23 | 0.090 |
Why?
|
| Tetraethylammonium | 3 | 1996 | 4 | 0.090 |
Why?
|
| Male | 10 | 2012 | 15273 | 0.090 |
Why?
|
| Biophysical Phenomena | 3 | 1996 | 30 | 0.080 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 10 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 25 | 0.080 |
Why?
|
| Biophysics | 3 | 1996 | 36 | 0.080 |
Why?
|
| Transfection | 1 | 2010 | 121 | 0.080 |
Why?
|
| Naphthols | 1 | 2009 | 4 | 0.080 |
Why?
|
| Rhodamines | 1 | 2009 | 5 | 0.080 |
Why?
|
| Arginine | 2 | 2022 | 17 | 0.080 |
Why?
|
| Bronchi | 1 | 1989 | 12 | 0.080 |
Why?
|
| Lymphocytes | 3 | 2002 | 63 | 0.080 |
Why?
|
| Financing, Government | 1 | 2009 | 10 | 0.080 |
Why?
|
| Career Mobility | 1 | 2009 | 22 | 0.080 |
Why?
|
| Cattle | 3 | 1994 | 127 | 0.080 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2008 | 8 | 0.080 |
Why?
|
| Histamine | 1 | 2008 | 8 | 0.080 |
Why?
|
| Proton Pump Inhibitors | 1 | 2008 | 14 | 0.080 |
Why?
|
| Transcriptional Regulator ERG | 2 | 1998 | 2 | 0.080 |
Why?
|
| ERG1 Potassium Channel | 2 | 1998 | 2 | 0.080 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 2 | 1998 | 3 | 0.080 |
Why?
|
| Buffers | 2 | 1999 | 12 | 0.080 |
Why?
|
| Ions | 2 | 2015 | 54 | 0.080 |
Why?
|
| Rats, Wistar | 2 | 1998 | 52 | 0.080 |
Why?
|
| Trachea | 1 | 1989 | 49 | 0.070 |
Why?
|
| Mitogens | 2 | 1987 | 5 | 0.070 |
Why?
|
| Okadaic Acid | 1 | 2006 | 6 | 0.070 |
Why?
|
| Arachidonic Acids | 1 | 2006 | 8 | 0.070 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2006 | 6 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2007 | 32 | 0.070 |
Why?
|
| Electrodes | 1 | 2007 | 12 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2006 | 45 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 106 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 1996 | 119 | 0.070 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 68 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 1996 | 135 | 0.060 |
Why?
|
| Research Design | 1 | 2007 | 207 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 435 | 0.060 |
Why?
|
| Computer Simulation | 2 | 1998 | 199 | 0.060 |
Why?
|
| Fluoresceins | 1 | 2004 | 6 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 619 | 0.060 |
Why?
|
| Barium | 1 | 1984 | 13 | 0.060 |
Why?
|
| Charybdotoxin | 2 | 1996 | 2 | 0.060 |
Why?
|
| Electron Transport | 1 | 2003 | 4 | 0.060 |
Why?
|
| Diffusion | 2 | 1996 | 25 | 0.060 |
Why?
|
| Cytosol | 1 | 2022 | 43 | 0.050 |
Why?
|
| Female | 1 | 2019 | 15708 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2022 | 3 | 0.050 |
Why?
|
| Pulmonary Artery | 2 | 1994 | 44 | 0.050 |
Why?
|
| Dogs | 1 | 2022 | 184 | 0.050 |
Why?
|
| Stimulation, Chemical | 1 | 2001 | 9 | 0.050 |
Why?
|
| Transgenes | 1 | 2001 | 14 | 0.050 |
Why?
|
| Biological Transport, Active | 2 | 1991 | 12 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2001 | 44 | 0.050 |
Why?
|
| Myotonia Congenita | 1 | 1981 | 1 | 0.050 |
Why?
|
| Extracellular Space | 1 | 1981 | 10 | 0.050 |
Why?
|
| Kv1.3 Potassium Channel | 2 | 2000 | 3 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 8 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 15 | 0.040 |
Why?
|
| Metals, Heavy | 1 | 2000 | 7 | 0.040 |
Why?
|
| Electrochemistry | 1 | 2000 | 44 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 10 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2020 | 45 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 45 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 2000 | 7 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 79 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2000 | 87 | 0.040 |
Why?
|
| Solubility | 1 | 1999 | 27 | 0.040 |
Why?
|
| Proteins | 1 | 2000 | 67 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 82 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2000 | 177 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2000 | 308 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 362 | 0.040 |
Why?
|
| Electrolytes | 2 | 1994 | 13 | 0.040 |
Why?
|
| Ion Transport | 2 | 2000 | 31 | 0.040 |
Why?
|
| Sarcolemma | 1 | 1978 | 7 | 0.040 |
Why?
|
| Colchicine | 1 | 1978 | 10 | 0.040 |
Why?
|
| Motor Neurons | 1 | 1978 | 18 | 0.040 |
Why?
|
| 4-Aminopyridine | 2 | 1996 | 5 | 0.040 |
Why?
|
| Time Factors | 3 | 2002 | 1490 | 0.040 |
Why?
|
| Concanavalin A | 2 | 1987 | 2 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 38 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 8 | 0.030 |
Why?
|
| Apamin | 1 | 1996 | 3 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 1996 | 12 | 0.030 |
Why?
|
| Base Sequence | 1 | 1996 | 107 | 0.030 |
Why?
|
| Mice, Inbred Strains | 3 | 2000 | 31 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 120 | 0.030 |
Why?
|
| Egtazic Acid | 1 | 1995 | 12 | 0.030 |
Why?
|
| Tritium | 1 | 2015 | 8 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 10 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 48 | 0.030 |
Why?
|
| Amphibians | 1 | 1994 | 2 | 0.030 |
Why?
|
| Vertebrates | 1 | 1994 | 2 | 0.030 |
Why?
|
| Amiloride | 1 | 1994 | 5 | 0.030 |
Why?
|
| Muscle Relaxation | 1 | 1994 | 3 | 0.030 |
Why?
|
| Rana temporaria | 2 | 1984 | 7 | 0.030 |
Why?
|
| Rana catesbeiana | 2 | 1984 | 9 | 0.030 |
Why?
|
| Half-Life | 1 | 1994 | 12 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1994 | 6 | 0.030 |
Why?
|
| Rana pipiens | 2 | 1984 | 51 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1994 | 106 | 0.030 |
Why?
|
| NADPH Oxidase 5 | 1 | 2012 | 1 | 0.020 |
Why?
|
| Sperm Motility | 1 | 2012 | 3 | 0.020 |
Why?
|
| Cell Separation | 1 | 1991 | 29 | 0.020 |
Why?
|
| Phencyclidine | 1 | 1990 | 1 | 0.020 |
Why?
|
| Tacrine | 1 | 1990 | 1 | 0.020 |
Why?
|
| Chlorpromazine | 1 | 1990 | 4 | 0.020 |
Why?
|
| Quinidine | 1 | 1990 | 2 | 0.020 |
Why?
|
| Gallopamil | 1 | 1990 | 8 | 0.020 |
Why?
|
| Scorpion Venoms | 1 | 1990 | 4 | 0.020 |
Why?
|
| Nifedipine | 1 | 1990 | 6 | 0.020 |
Why?
|
| Capsaicin | 1 | 1990 | 9 | 0.020 |
Why?
|
| Cations | 2 | 1987 | 16 | 0.020 |
Why?
|
| Mice, Mutant Strains | 2 | 1987 | 26 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2010 | 10 | 0.020 |
Why?
|
| Syk Kinase | 1 | 2010 | 10 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 15 | 0.020 |
Why?
|
| Action Potentials | 2 | 1988 | 89 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 57 | 0.020 |
Why?
|
| Calcium Channels | 1 | 1990 | 112 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 53 | 0.020 |
Why?
|
| Mitochondria | 1 | 2010 | 71 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 1989 | 10 | 0.020 |
Why?
|
| Phosphines | 1 | 1988 | 1 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1988 | 26 | 0.020 |
Why?
|
| Phytohemagglutinins | 2 | 1984 | 4 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 1987 | 192 | 0.020 |
Why?
|
| Lanthanum | 1 | 1985 | 2 | 0.020 |
Why?
|
| Cell Division | 1 | 1984 | 83 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 10 | 0.010 |
Why?
|
| Intercostal Muscles | 1 | 1982 | 3 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 1987 | 18 | 0.010 |
Why?
|
| Azacosterol | 1 | 1981 | 1 | 0.010 |
Why?
|
| Goats | 1 | 1981 | 7 | 0.010 |
Why?
|
| Delayed Rectifier Potassium Channels | 1 | 2000 | 2 | 0.010 |
Why?
|
| Neurotoxins | 1 | 2000 | 16 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2000 | 45 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 139 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1978 | 5 | 0.010 |
Why?
|
| Anions | 1 | 1987 | 5 | 0.000 |
Why?
|
| Drosophila | 1 | 1986 | 8 | 0.000 |
Why?
|
| Killer Cells, Natural | 1 | 1985 | 49 | 0.000 |
Why?
|
| Osmosis | 1 | 1985 | 6 | 0.000 |
Why?
|
| Cations, Monovalent | 1 | 1985 | 11 | 0.000 |
Why?
|
| Aminopyridines | 1 | 1984 | 1 | 0.000 |
Why?
|
| Thymidine | 1 | 1984 | 7 | 0.000 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1984 | 4 | 0.000 |
Why?
|
| Leucine | 1 | 1984 | 11 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1984 | 19 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1984 | 27 | 0.000 |
Why?
|
| Interleukin-2 | 1 | 1984 | 24 | 0.000 |
Why?
|
| Diltiazem | 1 | 1984 | 8 | 0.000 |
Why?
|